Role of fibrinogen in predicting complications in diabetes.
Not Applicable
- Conditions
- Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complicationsHealth Condition 2: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2019/01/016823
- Lead Sponsor
- KASTURBA MEDICAL COLLEGE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Type 2 diabetes mellitus patient without microvascular complications.
2. Type 2 diabetes mellitus patient with microvascular complications
Exclusion Criteria
1. Clinical/Laboratory evidence of liver dysfunction
2. Malignancy
3. Cerebrovascular disease / Peripheral vascular disease
4. History of coagulation disease
5. Pregnancy
6. Patients with chronic kidney dysfunction
7. Patients not giving consent
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum fibrinogen levels are found to be higher in T2DM with complications as compared to diabetic controls. <br/ ><br> <br/ ><br> <br/ ><br>Timepoint: Duration of diabetes mellitus
- Secondary Outcome Measures
Name Time Method Serum fibrinogen is an independent risk factor with high predicting power for microvascular complications in patients with T2DMTimepoint: Duration of diabetes mellitus